healthcare

healthcare Articles

Spark Therapeutics shares more than doubled in Tuesday’s session as the result of its pending acquisition. However, the root of the buyout was its gene therapy, which could drive more acquisitions...
Spark Therapeutics shares more than doubled to start out the week after the company announced that it would be acquired by Swiss health care giant Roche, which is looking to add to its portfolio.
Clementia Pharmaceuticals has entered into an agreement to be acquired by French pharmaceutical company Ipsen.
Voyager Therapeutics shares made an incredible gain on Friday after the firm announced a collaboration with pharma giant AbbVie.
Immune Design shares absolutely exploded on Thursday after Merck announced that it would be acquiring the firm at what some might call a ridiculous premium
For more than half a decade, the United States has seen an incredible rise of an opioid epidemic within its borders. According to a recent study, drug makers and federal regulators are the ones to...
Intercept Pharmaceuticals shares jumped on Tuesday after the firm announced results for its Phase 3 Regenerate study of obeticholic acid in patients with liver fibrosis due to nonalcoholic...
President Donald Trump had his annual physical. He weighs 243 pounds and stands six feet and three inches tall. That gives him a body mass index of 30.4, which is considered “obese.” About 40% of...
On Wednesday, Johnson & Johnson announced that a subsidiary had entered a definitive agreement to acquire a robotic technology firm focused on lung cancer.
Teva released mixed fourth-quarter financial results before the markets opened on Wednesday and its shares pulled back.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The January 31 short interest data have been compared with the previous report, and short interest in...
The January 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
The U.S. FDA and the FTC have sent warning letters to three makers and distributors of products that make unsubstantiated claims of providing relief or cures from a variety of diseases, including...
Short seller Muddy Waters LLC dropped a report Friday forecasting that medical device maker Inogen's share price will drop 67% to $46 from its current level around $140.
Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in February and March.